Search
My Cart

Thalidomide

SKU
T-1020
  • CAS:50-35-1
  • Formula:C13H10N2O4
  • MW:258.2
  • Appearance:White powder
  • Purity:>98%

1

2

3

SDS
CofA
Product Name Qty
Thalidomide
100 mg
$93.40
Thalidomide
500 mg
$364.51
Add to Compare Email
Loading...

Description

Thalidomide binds to the E3 ubiquitin ligase complex formed between CRBN, DDB1 and Cul4A inhibiting ligase activity. Inhibits TNFα synthesis and FGF-induced angiogenesis. Cell permeable.

Caution: Teratogenic. Pregnant women should avoid using this compound.

 

References

• Identification of a Primary Target of Thalidomide Teratogenicity

• Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency

• Thalidomide is an inhibitor of angiogenesis

 

Not for human therapeutic use or for medicinal purposes. For research applications only.

More Information
Alternate Name/Synonyms
(+/-)-Thalidomide; Thalomid; N-(2,6-dioxo-3-piperidinyl)phthalimide (racemic); Sedoval; Corronarobetin
SKU
T-1020
CAS #
50-35-1
Chemical Name
2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
Chemical Formula
C13H10N2O4
Molecular Weight
258.2
Appearance
White powder
Purity
>98%
Solubility
May be dissolved in DMSO
Melting Point
269-271ºC
Storage Temp
Room temperature
THERAPEUTIC AREA
Oncological Disorders
USE
A selective inhibitor of TNF alpha biosynthesis shown to have immunomodulatory and antiangeogenic activity
Merck Index
13.9326.2001
MDL NUMBER
MFCD00153873
CHEMACX
X1002033-8
INCHI
InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
SMILES
c1ccc2c(c1)C(=O)N(C2=O)C3CCC(=O)NC3=O
RTECS
TI4375000
UN #'S
UN 2811
PACKING GROUP
III
Handling
Avoid contact with skin, eyes or clothing. Use personal protective equipment as required. Wash contaminated clothing before reuse. Do not breathe dust/fume/gas/mist/vapors/spray. Do not eat, drink or smoke when using this product.
Special Shipping
Yes
Certificate of Analysis 1
T-1020, L1310.pdf
Certificate of Analysis 2
T-1020_T-1020,_A10050.pdf
GHS PICTOGRAMS
Handling Avoid contact with skin, eyes or clothing. Use personal protective equipment as required. Wash contaminated clothing before reuse. Do not breathe dust/fume/gas/mist/vapors/spray. Do not eat, drink or smoke when using this product.
UN #'S UN 2811
Packing Group III
Citations Thalidomide and irradiation combination therapy increases substance P levels in vitro
Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy
Related Products
To Top